VANCOMYCIN THERAPEUTIC DRUG-MONITORING - IS IT NECESSARY

被引:0
|
作者
FREEMAN, CD
QUINTILIANI, R
NIGHTINGALE, CH
机构
[1] HARTFORD HOSP, DEPT RES, ERC BLDG, 80 SEYMOUR ST, HARTFORD, CT 06115 USA
[2] HARTFORD HOSP, DIV INFECT DIS ALLERGY IMMUNOL, HARTFORD, CT 06115 USA
[3] UNIV CONNECTICUT, SCH MED, DEPT MED, HARTFORD, CT 06112 USA
[4] UNIV CONNECTICUT, SCH PHARM, HARTFORD, CT 06112 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the literature and assess the validity of obtaining vancomycin serum drug concentrations in patients. DATA SOURCES: A MEDLINE search of the English literature and a bibliographic review of articles pertaining to vancomycin serum concentrations, their use, and the rationale of cited therapeutic ranges. STUDY SELECTION AND DATA EXTRACTION: Studies pertaining to the use of vancomycin concentrations in the clinical setting, methods for predicting these concentrations, and studies that reported efficacy or toxicity associated with vancomycin use and possible correlation of serum concentrations. DATA SYNTHESIS: The usefulness of vancomycin serum concentrations, the determination of a therapeutic range of values, and their correlation to antibacterial efficacy and drug toxicity in the clinical setting are controversial. Old reports of toxicities need to be critically examined due to lack of information and the actual frequency of toxic reactions. The efficacy of vancomycin's antibacterial effect and its correlation with reported therapeutic ranges may advocate obtaining a vancomycin trough concentration in certain groups of patients. CONCLUSIONS: Determination of serum vancomycin concentrations in the clinical setting and their usefulness in patient care is questionable and unnecessary in the majority of patients.
引用
收藏
页码:594 / 598
页数:5
相关论文
共 50 条
  • [21] THERAPEUTIC DRUG-MONITORING IN PEDIATRICS
    HICKS, JMB
    CLINICAL BIOCHEMISTRY, 1983, 16 (06) : 355 - 356
  • [22] PRINCIPLES OF THERAPEUTIC DRUG-MONITORING
    BURKE, MD
    POSTGRADUATE MEDICINE, 1981, 70 (01) : 57 - 63
  • [23] AUDIT OF THERAPEUTIC DRUG-MONITORING
    HALLWORTH, MJ
    ANNALS OF CLINICAL BIOCHEMISTRY, 1988, 25 : 121 - 128
  • [24] THERAPEUTIC DRUG-MONITORING OF BUPROPION
    PRESKORN, SH
    FLECK, RJ
    SCHROEDER, DH
    AMERICAN JOURNAL OF PSYCHIATRY, 1990, 147 (12): : 1690 - 1691
  • [25] MISUSE OF THERAPEUTIC DRUG-MONITORING
    DOWSE, R
    KANFER, I
    SOUTH AFRICAN MEDICAL JOURNAL, 1987, 71 (06): : 405 - 405
  • [26] IMMUNOASSAY IN THERAPEUTIC DRUG-MONITORING
    JUARISTI, E
    JOURNAL OF CHEMICAL EDUCATION, 1983, 60 (09) : 721 - 724
  • [27] THERAPEUTIC DRUG-MONITORING OF RETINOIDS
    KLEIN, J
    FERNANDES, D
    PASTUSZAK, A
    KOREN, G
    THERAPEUTIC DRUG MONITORING, 1992, 14 (03) : 197 - 202
  • [28] THERAPEUTIC DRUG-MONITORING OF METHOTREXATE
    STUART, JFB
    MCVIE, JG
    CALMAN, KC
    LAWRENCE, JR
    STEELE, WH
    BRITISH JOURNAL OF CANCER, 1980, 42 (01) : 192 - 192
  • [29] THERAPEUTIC DRUG-MONITORING IN CARDIOLOGY
    OCHS, HR
    ZEITSCHRIFT FUR KARDIOLOGIE, 1984, 73 (10): : 605 - 612
  • [30] RATIONAL THERAPEUTIC DRUG-MONITORING
    WOJSLAW, A
    HOSPITAL FORMULARY, 1989, 24 (12): : 725 - 726